ENDRA LIFE SCIENCES INC. Proceeds from Convertible Debt
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Convertible Debt of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2021-03-25
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for the quarter ending 2019-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for the quarter ending 2019-09-30 was $2.49M.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for the quarter ending 2018-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for the quarter ending 2018-09-30 was $0.00.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for fiscal 2019 was $2.49M, a 166.28% increase from fiscal 2018.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for fiscal 2018 was $935.30K, a 315.69% increase from fiscal 2017.
- ENDRA LIFE SCIENCES INC. proceeds from convertible debt for fiscal 2017 was $225.00K, a 82.06% decline from fiscal 2016.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.49M derived: sum of 2 quarters · filed 2021-03-25 | $2.49M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $2.49M 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $0.00 derived: sum of 2 quarters · filed 2020-03-26 | $935.30K derived: sum of 3 quarters · filed 2020-03-26 | $935.30K 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $935.30K derived: sum of 2 quarters · filed 2019-11-13 | $935.30K 10-Q · filed 2019-11-13 | $935.30K derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $935.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $935.30K 10-Q · filed 2019-08-08 | $935.30K derived: sum of 3 quarters · filed 2019-08-08 | $935.30K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $0.00 derived: sum of 3 quarters · filed 2019-03-11 | $0.00 derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $0.00 derived: sum of 3 quarters · filed 2019-03-11 | $225.00K 10-K · filed 2019-03-11 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 derived: sum of 2 quarters · filed 2018-11-05 | $225.00K 10-Q · filed 2018-11-05 | $93.00K derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $225.00K 10-Q · filed 2018-08-13 | $93.00K derived: sum of 3 quarters · filed 2018-08-13 | $280.00K derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $225.00K 10-Q · filed 2018-05-15 | $93.00K derived: sum of 2 quarters · filed 2018-05-15 | $280.00K derived: sum of 3 quarters · filed 2018-05-15 | $1.48M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $55.00K derived: sum of 2 quarters · filed 2018-03-20 | $1.25M derived: sum of 3 quarters · filed 2018-03-20 | $1.25M 10-K · filed 2018-03-20 |
| 2016-09-30 | $187.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $1.39M derived: sum of 2 quarters · filed 2017-11-14 | $1.39M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $1.20M 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |